Unnati Pharmax

Morr 10 Topical Solution
Composition: Minoxidil Topical Solution 10% w/v
International Trade Name: Rogaine® / Regaine®

Morr 10 Solution is a high-strength Minoxidil topical formulation, developed as a pharmaceutical equivalent of the internationally recognized hair regrowth treatments marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Morr 10 Solution is supplied by trusted pharmaceutical exporters from India to support advanced global hair loss management programs, particularly in moderate to severe androgenetic alopecia.

Minoxidil is a potent vasodilator that enhances blood circulation to the scalp, revitalizes dormant hair follicles, and prolongs the anagen (growth) phase of the hair cycle. Morr 10 Minoxidil Solution is primarily indicated for the treatment of androgenetic alopecia in men, especially in patients who have shown limited response to lower-strength Minoxidil formulations, helping reduce progressive hair loss and promote visible hair regrowth with consistent use.

Minoxidil 10% solution, Morr 10 topical solution, high-strength Minoxidil, hair regrowth treatment, androgenetic alopecia therapy, advanced topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Morr 10 Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, specialty pharmacies, and international pharmaceutical distributors.

Morr F 10 Topical Solution
Composition: Minoxidil Topical Solution 10% w/v
International Trade Name: Rogaine® / Regaine®

Morr F 10 Solution is a high-quality Minoxidil topical formulation, developed as a pharmaceutical equivalent of the internationally recognized hair regrowth treatments marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Morr F 10 Solution is supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, particularly in androgenetic alopecia in men and women.

Minoxidil is a clinically proven vasodilator that improves blood circulation to the scalp, revitalizes dormant hair follicles, and prolongs the anagen (growth) phase of the hair cycle. Morr F 10 Minoxidil Solution is primarily indicated for the treatment of androgenetic alopecia, helping to reduce hair fall and promote visible hair regrowth with regular use.

Minoxidil 10% solution, Morr F 10 topical solution, Rogaine equivalent, hair regrowth treatment, androgenetic alopecia therapy, topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Morr F 10 Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Morr-F 3% Topical Solution
Composition: Minoxidil 3% w/v + Finasteride 0.1% w/v
International Trade Name: Minoxidil + Finasteride Topical Combination

Morr-F 3% is a high-quality topical formulation combining Minoxidil 3% with Finasteride 0.1%, designed to provide dual-action therapy for the management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Morr-F 3% Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil stimulates hair follicles, improves scalp microcirculation, and prolongs the anagen (growth) phase of the hair cycle, while Finasteride inhibits 5-alpha-reductase at the scalp, reducing local dihydrotestosterone (DHT) responsible for hair follicle miniaturization. Morr-F 3% Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible regrowth with regular use under medical supervision.

Minoxidil 3% solution, Finasteride 0.1% topical, Morr-F 3% solution, combination hair loss therapy, DHT-blocking topical treatment, androgenetic alopecia management, hair regrowth solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Morr-F 3% Minoxidil & Finasteride Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Morr-F 10 Topical Solution
Composition: Minoxidil 10% w/v + Finasteride 0.1% w/v
International Trade Name: Minoxidil + Finasteride Topical Combination

Morr-F 10 is a high-potency topical formulation combining Minoxidil 10% with Finasteride 0.1%, designed to deliver advanced dual-action therapy for androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Morr-F 10 Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil 10% stimulates hair follicles, improves scalp blood circulation, and prolongs the anagen (growth) phase of the hair cycle, while Finasteride 0.1% inhibits 5-alpha-reductase at the scalp, reducing local dihydrotestosterone (DHT) that causes hair follicle miniaturization. Morr-F 10 Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, improve hair density, and promote visible regrowth with consistent use under medical supervision.

Minoxidil 10% solution, Finasteride 0.1% topical, Morr-F 10 solution, combination hair loss therapy, DHT-blocking topical treatment, androgenetic alopecia management, hair regrowth solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Morr-F 10 Minoxidil & Finasteride Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Brintop-F 5% Topical Solution
Composition: Minoxidil 5% w/v + Finasteride 0.1% w/v
International Trade Name: Minoxidil + Finasteride Topical Combination

Brintop-F 5% is a high-quality topical formulation combining Minoxidil 5% with Finasteride 0.1%, designed to deliver effective dual-action therapy for the management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Brintop-F Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil 5% stimulates hair follicles, increases scalp blood circulation, and prolongs the anagen (growth) phase of the hair cycle, while Finasteride 0.1% inhibits 5-alpha-reductase at the scalp level, reducing dihydrotestosterone (DHT) responsible for hair follicle miniaturization. Brintop-F 5% Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible regrowth with regular use under medical supervision.

Minoxidil 5% solution, Finasteride 0.1% topical, Brintop-F solution, combination hair loss therapy, DHT-blocking topical treatment, androgenetic alopecia management, pharmaceutical exporter India, and dermatology product manufacturer India.

Brintop-F Minoxidil & Finasteride Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Minokem-N Topical Solution
Composition: Minoxidil + Azelaic Acid Topical Solution
International Trade Name: Rogaine® (Minoxidil)

Minokem-N is a combination topical hair loss formulation containing Minoxidil and Azelaic Acid, developed to provide enhanced management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Minokem-N Solution is supplied by trusted pharmaceutical exporters from India to support global hair restoration and dermatology treatment programs.

Minoxidil works by increasing blood flow to hair follicles, prolonging the anagen (growth) phase of the hair cycle and stimulating follicular activity, while Azelaic Acid helps inhibit local dihydrotestosterone (DHT) activity on the scalp, reducing follicular miniaturization. Minokem-N Topical Solution is primarily indicated for the treatment of male and female pattern hair loss, especially in patients requiring dual-action therapy to control hair fall and promote healthier, denser hair growth.

Minokem-N solution, Minoxidil with Azelaic Acid, combination hair loss therapy, DHT-blocking topical solution, androgenetic alopecia treatment, hair regrowth solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Minokem-N Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Minoxytop Tablets
Composition: Minoxidil Oral Tablets
International Trade Name: Loniten®

Minoxytop is a high-quality oral Minoxidil tablet, formulated as a pharmaceutical equivalent of the internationally recognized brand Loniten®. Manufactured in WHO-GMP certified facilities, Minoxytop Tablets are supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, particularly for patients with moderate to severe androgenetic alopecia who require systemic therapy.

Oral Minoxidil is a potent vasodilator that improves blood circulation to hair follicles, prolongs the anagen (growth) phase of the hair cycle, and stimulates follicular activity. Minoxytop Tablets are primarily indicated for the treatment of male and female pattern hair loss, especially in patients who show limited response to topical Minoxidil solutions, helping to reduce hair fall and promote visible hair regrowth.

Minoxidil tablets, Minoxytop oral Minoxidil, Loniten equivalent, systemic hair regrowth therapy, androgenetic alopecia treatment, pharmaceutical exporter India, and dermatology tablet manufacturer India.

Minoxytop Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, hospitals, specialty pharmacies, and international pharmaceutical distributors.

Tinfal-F Topical Solution
Composition: Minoxidil + Finasteride Topical Solution
International Trade Name: Minoxidil + Finasteride Topical Combination

Tinfal-F is a high-quality topical solution combining Minoxidil and Finasteride, formulated to provide dual-action therapy for the management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Tinfal-F Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil works by stimulating hair follicles and prolonging the anagen (growth) phase of the hair cycle, while Finasteride acts by inhibiting 5-alpha-reductase, reducing scalp levels of dihydrotestosterone (DHT), the primary hormone responsible for hair follicle miniaturization. Tinfal-F Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible regrowth when used regularly under medical supervision.

Minoxidil and Finasteride solution, Tinfal-F topical solution, combination hair loss treatment, DHT blocker topical therapy, androgenetic alopecia management, hair regrowth solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Tinfal-F Minoxidil & Finasteride Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Minokem-N Topical Solution
Composition: Minoxidil + Tretinoin + Azelaic Acid Topical Solution
International Trade Name: Minoxidil Combination Topical Therapy

Minokem-N is a high-quality topical formulation combining Minoxidil, Tretinoin, and Azelaic Acid, designed for advanced hair restoration therapy in androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Minokem-N Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair care treatment programs.

Minoxidil stimulates hair follicles, increases scalp microcirculation, and prolongs the anagen (growth) phase of the hair cycle. Tretinoin enhances the absorption and efficacy of Minoxidil while promoting scalp cellular turnover, and Azelaic Acid helps inhibit 5-alpha-reductase locally, reducing dihydrotestosterone (DHT) levels at the scalp. Minokem-N Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible hair regrowth with consistent use under medical supervision.

Minoxidil + Tretinoin + Azelaic Acid solution, Minokem-N topical, combination hair regrowth therapy, DHT-blocking topical treatment, androgenetic alopecia management, advanced hair restoration solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Minokem-N Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Morr-F 5% Topical Solution
Composition: Minoxidil 5% w/v + Finasteride 0.1% w/v
International Trade Name: Minoxidil + Finasteride Topical Combination

Morr-F 5% is a high-quality topical formulation combining Minoxidil 5% with Finasteride 0.1%, designed to provide dual-action therapy for the management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Morr-F 5% Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil stimulates hair follicles, improves scalp blood circulation, and prolongs the anagen (growth) phase of the hair cycle, while Finasteride inhibits 5-alpha-reductase at the scalp, reducing local dihydrotestosterone (DHT) responsible for hair follicle miniaturization. Morr-F 5% Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible regrowth with consistent use under medical supervision.

Minoxidil 5% solution, Finasteride 0.1% topical, Morr-F 5% solution, combination hair loss therapy, DHT-blocking topical treatment, androgenetic alopecia management, hair regrowth solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Morr-F 5% Minoxidil & Finasteride Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Morr 12.5 Topical Solution
Composition: Minoxidil Topical Solution 12.5% w/v
International Trade Name: Rogaine® / Regaine®

Morr 12.5 Solution is a high-strength Minoxidil topical formulation, developed as a pharmaceutical equivalent of the internationally recognized hair regrowth treatments marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Morr Solution is supplied by trusted pharmaceutical exporters from India to support advanced global hair loss management programs, particularly in cases of severe or treatment-resistant androgenetic alopecia.

Minoxidil is a potent vasodilator that enhances scalp blood circulation, stimulates dormant hair follicles, and prolongs the anagen (growth) phase of the hair cycle. Morr 12.5 Minoxidil Solution is primarily indicated for the management of androgenetic alopecia in men, especially in patients who have shown limited response to lower-strength Minoxidil formulations, helping to reduce progressive hair loss and promote visible hair regrowth with consistent use.

Morr 12.5 solution, Minoxidil 12.5% topical solution, high-strength Minoxidil, hair regrowth treatment, androgenetic alopecia therapy, advanced topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Morr 12.5 Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, specialty pharmacies, and international pharmaceutical distributors.

Minichek 5% Solution
Composition: Minoxidil Topical Solution 5% w/v
International Trade Name: Rogaine® / Regaine®

Minichek 5% Solution is a high-quality Minoxidil topical formulation, a pharmaceutical equivalent of the internationally recognized hair regrowth treatment marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Minichek Solution is supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, particularly in androgenetic alopecia.

Minoxidil is a potent vasodilator that works by improving blood flow to hair follicles, prolonging the anagen (growth) phase of the hair cycle and stimulating follicular activity. Minichek 5% Minoxidil Solution is primarily indicated for the treatment of male and female pattern hair loss, helping to reduce hair fall and promote visible hair regrowth with regular application.

Minoxidil 5% solution, Minichek topical solution, Rogaine equivalent, hair regrowth treatment, androgenetic alopecia therapy, topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Minichek 5% Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

GAIN Topical Solution
Composition: Minoxidil 10% w/v + Finasteride 0.1% w/v
International Trade Name: Minoxidil + Finasteride Topical Combination

GAIN is a high-potency topical hair loss treatment combining Minoxidil 10% with Finasteride 0.1%, formulated to deliver advanced dual-action therapy for androgenetic alopecia. Manufactured in WHO-GMP certified facilities, GAIN Topical Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil 10% works by enhancing blood flow to hair follicles and prolonging the anagen (growth) phase of the hair cycle, while Finasteride 0.1% inhibits 5-alpha-reductase activity at the scalp, reducing local dihydrotestosterone (DHT) levels responsible for follicular miniaturization. GAIN Topical Solution is primarily indicated for the management of moderate to advanced male pattern hair loss, helping to reduce hair fall, improve hair density, and promote visible regrowth with consistent use under medical supervision.

Minoxidil 10% solution, Finasteride 0.1% topical, GAIN hair loss solution, combination alopecia therapy, DHT-blocking topical treatment, advanced hair regrowth formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

GAIN Minoxidil & Finasteride Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

MinoxyPark 5mg Tablet
Composition: Minoxidil 5mg
International Trade Name: Loniten® / Rogaine® (Minoxidil)

MinoxyPark is a high-quality Minoxidil 5mg oral tablet formulated to support hair regrowth therapy in cases of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, MinoxyPark Tablets are supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil works by stimulating hair follicles, improving scalp blood circulation, and prolonging the anagen (growth) phase of the hair cycle. MinoxyPark 5mg Tablet is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible regrowth under medical supervision.

Minoxidil 5mg tablet, MinoxyPark tablet, oral hair regrowth therapy, androgenetic alopecia treatment, male pattern baldness management, pharmaceutical exporter India, and dermatology product manufacturer India.

MinoxyPark Minoxidil 5mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, specialty pharmacies, and international pharmaceutical distributors.

Avosteride 0.5 Capsules
Composition: Dutasteride 0.5 mg
International Trade Name: Avodart®

Avosteride 0.5 is a high-quality Dutasteride capsule, a trusted pharmaceutical equivalent of the internationally recognized brand Avodart®. Manufactured in WHO-GMP certified facilities, Avosteride Capsules are supplied by reputable pharmaceutical exporters from India to support global androgenetic alopecia management programs, particularly in men with male pattern baldness and benign prostatic hyperplasia (BPH).

Dutasteride is a potent dual 5-alpha-reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for hair follicle miniaturization and prostate enlargement. Avosteride 0.5 Capsules are primarily indicated for the treatment of androgenetic alopecia in men and for management of BPH, helping to reduce hair loss, promote hair regrowth, and improve urinary flow in patients with enlarged prostate.

Dutasteride 0.5 mg capsule, Avosteride capsule, Avodart equivalent, DHT blocker, male pattern hair loss treatment, BPH management, pharmaceutical exporter India, and dermatology & urology capsule manufacturer India.

Avosteride 0.5 Capsules are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, hospitals, online pharmacies, and international pharmaceutical distributors.

Duprost 0.5mg Capsule
Composition: Dutasteride 0.5mg
International Trade Name: Avodart®

Duprost is a high-quality Dutasteride 0.5mg capsule, a trusted pharmaceutical equivalent of the internationally recognized hair loss and benign prostatic hyperplasia (BPH) treatment marketed under the brand name Avodart®. Manufactured in WHO-GMP certified facilities, Duprost Capsules are supplied by reputable pharmaceutical exporters from India to support global androgenetic alopecia and urology treatment programs.

Dutasteride is a dual 5-alpha-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), a key hormone responsible for hair follicle miniaturization and prostate enlargement. Duprost 0.5mg Capsule is primarily indicated for the treatment of male pattern hair loss (androgenetic alopecia) and benign prostatic hyperplasia, helping to slow hair loss, promote hair regrowth, and manage prostate symptoms under medical supervision.

Dutasteride 0.5mg capsule, Duprost capsule, Avodart equivalent, DHT inhibitor, male pattern baldness therapy, BPH treatment, pharmaceutical exporter India, and androgenetic alopecia management solution.

Duprost Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, urology centers, specialty pharmacies, and international pharmaceutical distributors.

Healpecia 1 Tablets
Composition: Finasteride 1 mg
International Trade Name: Propecia®

Healpecia 1 is a high-quality Finasteride 1 mg tablet, a trusted pharmaceutical equivalent of the internationally recognized hair loss treatment marketed under the brand name Propecia®. Manufactured in WHO-GMP certified facilities, Healpecia 1 Tablets are supplied by reputable pharmaceutical exporters from India to support global androgenetic alopecia management programs, particularly in men with male pattern baldness.

Finasteride is a selective 5-alpha-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), the primary hormone responsible for hair follicle miniaturization. Healpecia 1 Tablet is primarily indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men, helping to slow hair loss and promote hair regrowth.

Finasteride 1 mg tablet, Healpecia 1 tablet, Propecia equivalent, DHT inhibitor, male pattern baldness treatment, hair loss therapy, pharmaceutical exporter India, and androgenetic alopecia management solution.

Healpecia 1 Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, hospitals, online pharmacies, and international pharmaceutical distributors.

MinoxiBoon Tablets (5 mg & 10 mg)
Composition: Minoxidil Tablets 5 mg / 10 mg
International Trade Name: Loniten® (oral Minoxidil)

MinoxiBoon is a high-quality oral Minoxidil tablet available in 5 mg and 10 mg strengths, formulated as a pharmaceutical equivalent of the internationally recognized brand Loniten®. Manufactured in WHO-GMP certified facilities, MinoxiBoon Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hair loss management programs and specialized dermatology treatments.

Oral Minoxidil is a potent vasodilator that improves systemic blood flow and enhances nutrient delivery to hair follicles, thereby prolonging the anagen (growth) phase of the hair cycle and stimulating hair regrowth. MinoxiBoon 5 mg and 10 mg Tablets are primarily prescribed off-label for the management of moderate to severe androgenetic alopecia in men and women, particularly in patients who show inadequate response or intolerance to topical Minoxidil formulations.

MinoxiBoon tablet, oral Minoxidil 5 mg, oral Minoxidil 10 mg, Loniten equivalent, hair regrowth tablets, androgenetic alopecia treatment, pharmaceutical exporter India, and dermatology tablet manufacturer India.

MinoxiBoon Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, hospitals, specialty pharmacies, and international pharmaceutical distributors.

Hair 4U-F 5 Hair Solution
Composition: Minoxidil 5% w/v
International Trade Name: Rogaine® / Loniten® (Minoxidil)

Hair 4U-F 5 is a high-strength Minoxidil 5% topical hair solution formulated to support effective hair regrowth therapy. Manufactured in WHO-GMP certified facilities, Hair 4U-F 5 Solution is supplied by trusted pharmaceutical exporters from India to meet global dermatology and hair restoration treatment needs.

Minoxidil 5% acts by stimulating dormant hair follicles, improving scalp micro-circulation, and extending the anagen (growth) phase of the hair cycle. Hair 4U-F 5 Hair Solution is primarily indicated for the treatment of androgenetic alopecia in men, helping to reduce hair fall, improve hair thickness, and promote visible regrowth with regular use under medical supervision.

Minoxidil 5% solution, Hair 4U-F 5 hair solution, topical hair regrowth treatment, male pattern baldness therapy, androgenetic alopecia management, pharmaceutical exporter India, and dermatology product manufacturer India.

Hair 4U-F 5 Minoxidil Hair Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Minoxyqure-F Topical Solution (60 ml)
Composition: Minoxidil + Finasteride Topical Solution
International Trade Name: Rogaine® + Propecia® (combined therapy)

Minoxyqure-F is a combination topical solution containing Minoxidil and Finasteride, formulated to provide dual-action therapy for androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Minoxyqure-F 60 ml Solution is supplied by trusted pharmaceutical exporters from India to support advanced global hair loss management programs, offering enhanced efficacy for men with male pattern baldness.

Minoxidil is a clinically proven vasodilator that increases blood circulation to hair follicles, revitalizes dormant follicles, and prolongs the anagen (growth) phase of the hair cycle. Finasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for hair follicle miniaturization and progressive hair loss. Minoxyqure-F Minoxidil + Finasteride Topical Solution is primarily indicated for the treatment of androgenetic alopecia in men, helping to reduce hair fall, strengthen existing hair, and promote visible hair regrowth.

Minoxidil + Finasteride solution, Minoxyqure-F topical solution, dual-action hair loss therapy, DHT-blocking hair regrowth solution, androgenetic alopecia treatment, pharmaceutical exporter India, and dermatology product manufacturer India.

Minoxyqure-F Topical Solution (60 ml) is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Minoxyoure 5F Topical Solution
Composition: Minoxidil + Finasteride Topical Solution
International Trade Name: Rogaine® + Propecia® (combined therapy)

Minoxyoure 5F is a combination topical solution containing Minoxidil and Finasteride, formulated to provide dual-action therapy for androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Minoxyoure 5F Solution is supplied by trusted pharmaceutical exporters from India to support advanced global hair loss management programs, offering enhanced efficacy for men with male pattern baldness.

Minoxidil is a clinically proven vasodilator that increases blood flow to hair follicles, prolongs the anagen (growth) phase, and stimulates follicular activity. Finasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for follicle miniaturization and progressive hair loss. Minoxyoure 5F Minoxidil + Finasteride Solution is primarily indicated for the treatment of androgenetic alopecia in men, helping to reduce hair fall, strengthen existing hair, and promote visible hair regrowth.

Minoxidil + Finasteride solution, Minoxyoure 5F topical solution, dual-action hair loss therapy, DHT-blocking hair regrowth solution, androgenetic alopecia treatment, pharmaceutical exporter India, and dermatology product manufacturer India.

Minoxyoure 5F Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Tinfal 10F Topical Solution
Composition: Minoxidil + Finasteride Topical Solution
International Trade Name: Rogaine® + Propecia® (combined therapy)

Tinfal 10F is a combination topical solution containing Minoxidil and Finasteride, formulated to provide dual-action therapy for androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Tinfal 10F Solution is supplied by trusted pharmaceutical exporters from India to support advanced global hair loss management programs, offering enhanced efficacy for men with male pattern baldness.

Minoxidil is a clinically proven vasodilator that stimulates blood flow to hair follicles, revitalizes dormant follicles, and prolongs the anagen (growth) phase of the hair cycle. Finasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for hair follicle miniaturization and progressive hair loss. Tinfal 10F Minoxidil + Finasteride Topical Solution is primarily indicated for the treatment of androgenetic alopecia in men, helping to reduce hair fall, strengthen existing hair, and promote visible hair regrowth.

Minoxidil + Finasteride solution, Tinfal 10F topical solution, dual-action hair loss therapy, DHT-blocking hair regrowth solution, androgenetic alopecia treatment, pharmaceutical exporter India, and dermatology product manufacturer India.

Tinfal 10F Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Lonitab 2.5mg Tablet
Composition: Minoxidil 2.5mg
International Trade Name: Loniten® / Rogaine® (Minoxidil)

Lonitab is a high-quality Minoxidil 2.5mg oral tablet formulated to support hair regrowth therapy in androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Lonitab Tablets are supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil works by stimulating hair follicles, improving scalp microcirculation, and prolonging the anagen (growth) phase of the hair cycle. Lonitab 2.5mg Tablet is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible regrowth under medical supervision.

Minoxidil 2.5mg tablet, Lonitab tablet, oral hair regrowth therapy, androgenetic alopecia treatment, male pattern baldness management, pharmaceutical exporter India, and dermatology product manufacturer India.

Lonitab Minoxidil 2.5mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, specialty pharmacies, and international pharmaceutical distributors.

Lonitab 5mg Tablets
Composition: Minoxidil 5mg
International Trade Name: Loniten®

Lonitab is a high-quality Minoxidil 5mg tablet, a pharmaceutical equivalent of the internationally recognized antihypertensive medication marketed under the brand name Loniten®. Manufactured in WHO-GMP certified facilities, Lonitab Tablets are supplied by trusted pharmaceutical exporters from India to support global cardiovascular and specialized therapeutic treatment programs.

Minoxidil is a potent peripheral vasodilator that works by relaxing blood vessels and improving blood flow, thereby effectively reducing elevated blood pressure. Lonitab 5mg Tablets are primarily indicated for the treatment of severe or resistant hypertension, particularly in patients who do not respond adequately to conventional antihypertensive therapies. In selected cases, oral minoxidil is also prescribed off-label under medical supervision.

Minoxidil 5mg tablets, Lonitab tablet, Loniten equivalent, oral minoxidil, antihypertensive vasodilator, resistant hypertension treatment, pharmaceutical exporter India, and cardiovascular medicine manufacturer India.

Lonitab Minoxidil Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, cardiology clinics, specialty care centers, government health programs, and international pharmaceutical distributors.

Finalo 1mg Tablet
Composition: Finasteride 1mg
International Trade Name: Propecia®

Finalo is a high-quality Finasteride 1mg tablet, a trusted pharmaceutical equivalent of the internationally recognized hair loss treatment marketed under the brand name Propecia®. Manufactured in WHO-GMP certified facilities, Finalo Tablets are supplied by reputable pharmaceutical exporters from India to support global androgenetic alopecia management programs.

Finasteride is a selective 5-alpha-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), the primary hormone responsible for hair follicle miniaturization. Finalo 1mg Tablet is primarily indicated for the treatment of male pattern hair loss, helping to slow hair loss and promote hair regrowth in men when used under medical supervision.

Finasteride 1mg tablet, Finalo tablet, Propecia equivalent, DHT inhibitor, male pattern baldness treatment, hair loss therapy, pharmaceutical exporter India, and androgenetic alopecia management solution.

Finalo Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, specialty pharmacies, and international pharmaceutical distributors.

Finax 1 mg Tablets
Composition: Finasteride 1 mg
International Trade Name: Propecia®

Finax 1 mg is a high-quality Finasteride tablet, a trusted pharmaceutical equivalent of the internationally recognized hair loss treatment marketed under the brand name Propecia®. Manufactured in WHO-GMP certified facilities, Finax Tablets are supplied by reputable pharmaceutical exporters from India to support global androgenetic alopecia management programs, particularly in men with male pattern baldness.

Finasteride is a selective 5-alpha-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for hair follicle miniaturization. Finax 1 mg Tablet is primarily indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men, helping to slow hair loss and promote hair regrowth with continued therapy.

Finasteride 1 mg tablet, Finax tablet, Propecia equivalent, DHT inhibitor, male pattern baldness treatment, hair loss therapy, pharmaceutical exporter India, and androgenetic alopecia management solution.

Finax 1 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, hospitals, online pharmacies, and international pharmaceutical distributors.

Dutas 0.5 mg Capsules
Composition: Dutasteride 0.5 mg
International Trade Name: Avodart®

Dutas 0.5 mg is a high-quality Dutasteride capsule, a pharmaceutical equivalent of the internationally recognized brand Avodart®. Manufactured in WHO-GMP certified facilities, Dutas Capsules are supplied by trusted pharmaceutical exporters from India to support global androgenetic alopecia management programs and benign prostatic hyperplasia (BPH) therapy.

Dutasteride is a potent dual 5-alpha-reductase inhibitor that prevents the conversion of testosterone into dihydrotestosterone (DHT), the key hormone responsible for hair follicle miniaturization and prostate enlargement. Dutas 0.5 mg Capsules are primarily indicated for the treatment of androgenetic alopecia in men and for the management of BPH, helping reduce hair loss, promote hair regrowth, and improve urinary flow in patients with an enlarged prostate.

Dutasteride 0.5 mg capsule, Dutas capsule, Avodart equivalent, DHT blocker, male pattern hair loss treatment, BPH management, pharmaceutical exporter India, and dermatology & urology capsule manufacturer India.

Dutas 0.5 mg Capsules are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, hospitals, online pharmacies, and international pharmaceutical distributors.

Hair 4U Pro Topical Solution
Composition: Minoxidil + Finasteride Topical Solution
International Trade Name: Minoxidil + Finasteride Topical Combination

Hair 4U Pro is a high-quality topical formulation combining Minoxidil and Finasteride, designed to deliver advanced dual-action therapy for the management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Hair 4U Pro Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil works by stimulating hair follicles, enhancing scalp blood circulation, and prolonging the anagen (growth) phase of the hair cycle, while Finasteride inhibits 5-alpha-reductase at the scalp level, reducing local dihydrotestosterone (DHT) responsible for hair follicle miniaturization. Hair 4U Pro Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, improve hair density, and promote visible regrowth with consistent use under medical supervision.

Minoxidil and Finasteride solution, Hair 4U Pro topical solution, combination hair loss therapy, DHT-blocking topical treatment, androgenetic alopecia management, hair regrowth solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Hair 4U Pro Minoxidil & Finasteride Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Minoxytop 5 Topical Solution
Composition: Minoxidil Topical Solution 5% w/v
International Trade Name: Rogaine® / Regaine®

Minoxytop 5 is a high-quality Minoxidil topical solution, a pharmaceutical equivalent of the internationally recognized hair regrowth treatment marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Minoxytop Solution is supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, particularly in androgenetic alopecia.

Minoxidil is a clinically proven vasodilator that enhances blood circulation to the scalp, revitalizes hair follicles, and extends the anagen (growth) phase of the hair cycle. Minoxytop 5 Minoxidil Topical Solution is primarily indicated for the treatment of male and female pattern hair loss, helping to reduce hair fall and promote visible hair regrowth with consistent application.

Minoxytop 5 solution, Minoxidil 5% topical solution, Rogaine equivalent, hair regrowth treatment, androgenetic alopecia therapy, topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Minoxytop 5 Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Mintop 10 Topical Solution
Composition: Minoxidil Topical Solution 10% w/v
International Trade Name: Rogaine® / Regaine®

Mintop 10 is a high-strength Minoxidil topical solution, a pharmaceutical equivalent of the internationally recognized hair regrowth treatment marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Mintop Solution is supplied by trusted pharmaceutical exporters from India to support advanced global hair loss management programs, particularly in moderate to severe androgenetic alopecia.

Minoxidil is a potent vasodilator that improves blood circulation to the scalp, revitalizes hair follicles, and prolongs the anagen (growth) phase of the hair cycle. Mintop Minoxidil 10% Topical Solution is primarily indicated for the treatment of androgenetic alopecia in men, especially in patients with inadequate response to lower-strength Minoxidil formulations, helping reduce hair fall and promote visible hair regrowth with consistent use.

Mintop 10 solution, Minoxidil 10% topical solution, high-strength Minoxidil, hair regrowth treatment, androgenetic alopecia therapy, topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Mintop 10 Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Minoxytop 5 Topical Solution
Composition: Minoxidil Topical Solution 5% w/v
International Trade Name: Rogaine® / Regaine®

Minoxytop 5 is a high-quality Minoxidil topical formulation, developed as a pharmaceutical equivalent of the internationally recognized hair regrowth treatment marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Minoxytop Solution is supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, particularly in androgenetic alopecia.

Minoxidil is a clinically proven vasodilator that improves blood circulation to the scalp, revitalizes dormant hair follicles, and prolongs the anagen (growth) phase of the hair cycle. Minoxytop Minoxidil 5% Topical Solution is primarily indicated for the treatment of male and female pattern hair loss, helping to reduce hair fall and promote visible hair regrowth with regular use.

Minoxytop 5 solution, Minoxidil 5% topical, Rogaine equivalent, hair regrowth treatment, androgenetic alopecia therapy, topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Minoxytop 5 Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Regaine 5% Topical Solution
Composition: Minoxidil Topical Solution 5% w/v
International Trade Name: Rogaine® / Regaine®

Regaine 5% Solution is a high-quality Minoxidil topical formulation, developed as a pharmaceutical equivalent of the internationally recognized hair regrowth treatment marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Regaine 5% Solution is supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, particularly in androgenetic alopecia.

Minoxidil is a clinically proven vasodilator that enhances blood circulation to the scalp, revitalizes dormant hair follicles, and prolongs the anagen (growth) phase of the hair cycle. Regaine 5% Minoxidil Solution is primarily indicated for the treatment of male and female pattern hair loss, helping to reduce hair fall and promote visible hair regrowth with regular application.

Minoxidil 5% solution, Regaine topical solution, Rogaine equivalent, hair regrowth treatment, androgenetic alopecia therapy, topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Regaine 5% Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Minoxytop 2 Topical Solution
Composition: Minoxidil 2% w/v
International Trade Name: Rogaine® / Loniten® (Minoxidil)

Minoxytop 2 is a high-quality Minoxidil 2% topical solution formulated for the effective management of hair loss. Manufactured in WHO-GMP certified facilities, Minoxytop 2 Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil 2% works by stimulating hair follicles, improving scalp blood circulation, and prolonging the anagen (growth) phase of the hair cycle. Minoxytop 2 Topical Solution is primarily indicated for the treatment of early-stage androgenetic alopecia in men and women, helping to reduce hair fall, strengthen existing hair, and promote visible regrowth with regular use under medical supervision.

Minoxidil 2% solution, Minoxytop 2 topical, hair regrowth solution, androgenetic alopecia treatment, topical vasodilator for hair loss, pharmaceutical exporter India, and dermatology product manufacturer India.

Minoxytop 2 Minoxidil Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, specialty pharmacies, hair care centers, and international pharmaceutical distributors.

Tinfal 5 Topical Solution
Composition: Minoxidil 5% w/v
International Trade Name: Rogaine® / Loniten® (Minoxidil)

Tinfal 5 is a high-quality Minoxidil 5% topical solution formulated for effective management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Tinfal 5 Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil 5% works by stimulating hair follicles, improving scalp microcirculation, and prolonging the anagen (growth) phase of the hair cycle. Tinfal 5 Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible hair regrowth with regular use under medical supervision.

Minoxidil 5% solution, Tinfal 5 topical solution, hair regrowth treatment, androgenetic alopecia therapy, male pattern baldness management, pharmaceutical exporter India, and dermatology product manufacturer India.

Tinfal 5 Minoxidil Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Tinfal F Topical Solution
Composition: Minoxidil + Finasteride Topical Solution
International Trade Name: Rogaine® + Propecia® (combined therapy)

Tinfal F is a combination topical solution containing Minoxidil and Finasteride, formulated to provide dual-action therapy for androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Tinfal F Solution is supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, offering enhanced efficacy for men with male pattern baldness.

Minoxidil is a clinically proven vasodilator that increases blood circulation to hair follicles, prolongs the anagen (growth) phase, and stimulates follicular activity. Finasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for hair follicle miniaturization and progressive hair loss. Tinfal F Minoxidil + Finasteride Solution is primarily indicated for the treatment of androgenetic alopecia in men, helping to reduce hair fall, strengthen existing hair, and promote visible hair regrowth.

Minoxidil + Finasteride solution, Tinfal F topical solution, combination hair loss therapy, DHT-blocking hair regrowth solution, androgenetic alopecia treatment, pharmaceutical exporter India, and dermatology product manufacturer India.

Tinfal F Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Tugain 5 Topical Solution
Composition: Minoxidil Topical Solution 5% w/v
International Trade Name: Rogaine® / Regaine®

Tugain 5 Solution is a high-quality Minoxidil topical formulation, developed as a pharmaceutical equivalent of the internationally recognized hair regrowth treatments marketed under the brand names Rogaine® and Regaine®. Manufactured in WHO-GMP certified facilities, Tugain 5 Solution is supplied by trusted pharmaceutical exporters from India to support global hair loss management programs, particularly in androgenetic alopecia.

Minoxidil is a clinically proven vasodilator that improves blood circulation to the scalp, revitalizes dormant hair follicles, and prolongs the anagen (growth) phase of the hair cycle. Tugain 5 Minoxidil Solution is primarily indicated for the treatment of male and female pattern hair loss, helping to reduce hair fall and promote visible hair regrowth with consistent application.

Minoxidil 5% solution, Tugain 5 topical solution, Rogaine equivalent, hair regrowth treatment, androgenetic alopecia therapy, topical hair loss solution, pharmaceutical exporter India, and dermatology product manufacturer India.

Tugain 5 Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, hospitals, retail and online pharmacies, and international pharmaceutical distributors.

Minoxytop-F 5 Topical Solution
Composition: Minoxidil 5% w/v + Finasteride 0.1% w/v
International Trade Name: Minoxidil + Finasteride Topical Combination

Minoxytop-F 5 is a high-quality topical formulation combining Minoxidil 5% with Finasteride, designed to provide effective dual-action therapy for the management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Minoxytop-F 5 Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil works by stimulating hair follicles, improving scalp blood circulation, and extending the anagen (growth) phase of the hair cycle, while Finasteride inhibits 5-alpha-reductase at the scalp level, reducing local dihydrotestosterone (DHT) responsible for hair follicle miniaturization. Minoxytop-F 5 Topical Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, improve hair density, and promote visible regrowth with consistent use under medical supervision.

Minoxidil 5% solution, Finasteride topical, Minoxytop-F 5 solution, combination hair loss treatment, DHT blocker topical therapy, androgenetic alopecia management, pharmaceutical exporter India, and dermatology product manufacturer India.

Minoxytop-F 5 Minoxidil & Finasteride Topical Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

Finpecia 1mg Tablet
Composition: Finasteride 1mg
International Trade Name: Propecia®

Finpecia is a high-quality Finasteride 1mg tablet, a trusted pharmaceutical equivalent of the internationally recognized hair loss treatment marketed under the brand name Propecia®. Manufactured in WHO-GMP certified facilities, Finpecia Tablets are supplied by reputable pharmaceutical exporters from India to support advanced global androgenetic alopecia management programs, particularly in men with male pattern baldness.

Finasteride is a selective 5-alpha-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), the key hormone responsible for hair follicle miniaturization. Finpecia 1mg Tablet is primarily indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men, helping to slow hair loss and promote hair regrowth.

Finasteride 1mg tablet, Finpecia tablet, Propecia equivalent, DHT inhibitor, male pattern baldness treatment, hair loss therapy, pharmaceutical exporter India, and androgenetic alopecia management solution.

Finpecia Tablets are manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, government health programs, and international pharmaceutical distributors.

Tugain Men 10% Lipid Solution (Alcohol-Free)
Composition: Minoxidil 10% w/v
International Trade Name: Rogaine® / Loniten® (Minoxidil)

Tugain Men 10% is a high-strength alcohol-free Minoxidil 10% topical lipid solution formulated for effective management of androgenetic alopecia. Manufactured in WHO-GMP certified facilities, Tugain Men 10% Solution is supplied by trusted pharmaceutical exporters from India to support global dermatology and hair restoration treatment programs.

Minoxidil 10% works by stimulating hair follicles, improving scalp microcirculation, and prolonging the anagen (growth) phase of the hair cycle. The alcohol-free lipid formulation ensures better scalp tolerance, reduced dryness, and improved comfort during daily use. Tugain Men 10% Lipid Solution is primarily indicated for the treatment of male pattern hair loss, helping to reduce hair fall, strengthen existing hair, and promote visible hair regrowth with regular use under medical supervision.

Minoxidil 10% lipid solution, Tugain Men 10% topical, alcohol-free hair regrowth treatment, androgenetic alopecia therapy, male pattern baldness management, pharmaceutical exporter India, and dermatology product manufacturer India.

Tugain Men 10% Alcohol-Free Lipid Solution is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and long-term stability. The solution is supplied in secure, leak-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair transplant centers, specialty pharmacies, and international pharmaceutical distributors.

1. Proscalpin 1mg Tablet

   Composition: Finasteride 1mg
   International Trade Name: Propecia®

   Proscalpin is a high-quality Finasteride 1mg tablet, a trusted pharmaceutical equivalent of the internationally recognized hair loss treatment marketed under the brand name Propecia®. Manufactured in WHO-GMP certified facilities, Proscalpin Tablets are supplied by reputable pharmaceutical exporters from India to support global androgenetic alopecia management programs.

   Finasteride is a selective 5-alpha-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), the key hormone responsible for hair follicle miniaturization. Proscalpin 1mg Tablet is primarily indicated for the treatment of male pattern hair loss, helping to slow hair loss and promote hair regrowth when used under medical supervision.

   Finasteride 1mg tablet, Proscalpin tablet, Propecia equivalent, DHT inhibitor, male pattern baldness treatment, hair loss therapy, pharmaceutical exporter India, and androgenetic alopecia management solution.

   Proscalpin Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hair restoration centers, specialty pharmacies, and international pharmaceutical distributors.